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Purpose: The aim of this study was to evaluate the impact of a laparoscopic approach on
long-term oncological outcomes in curative intent surgery for pT4 colon cancer, in both
overall and stratiﬁed subgroups with distinct clinical entities.
Patients and methods: Patients with a pT4N0-2M0 colon cancer from four centers
between 2000 and 2014 were included. Laparoscopic and open approaches were compared
according to the intention-to-treat principle. Propensity scores were used to adjust for base-
line differences between the groups in three manners: i) as a linear predictor in a Cox
regression model, ii) to create a 1:1 matched cohort, and iii) to stratify patients into four
groups with an increasing chance of receiving laparoscopy.
Results: In total, 424 patients were included. After 1:1 matching, a laparoscopic approach
correlated with higher rates of radical resection, lower morbidity, and a higher percentage of
patients receiving adjuvant chemotherapy. This translated into better 5-year disease-free
survival (52% vs 40%, HR 0.70; 95% CI 0.50–0.96) and 5-year overall survival (68% vs
57%, HR 0.66; 95% CI 0.43–0.99). These results were conﬁrmed in the other two propensity
score analyses. In the multivariable models, adjuvant chemotherapy remained independently
associated with better survival, whereas surgical approach lost signiﬁcance.
Conclusions: In locally advanced colon cancer, an intentional laparoscopic approach in
experienced hands seems to decrease morbidity and to increase the proportion of patients
receiving adjuvant chemotherapy. Receiving adjuvant chemotherapy was independently
associated with improved survival.
Keywords: T4 colon cancer, laparoscopy, lower GI
Synopsis
In this multicenter propensity score analyses of 424 pT4N0-2M0 colon cancer
patients who underwent curative intent surgery, laparoscopic surgery compared to
open was associated with reduced postoperative morbidity and a higher percentage of
patients receiving adjuvant chemotherapy, which translated into improved survival.
Introduction
Resection of locally advanced (T4) colon cancer stage is still regarded as a relative
contraindication for laparoscopic surgery, because radicality of the resection (R0)
might be jeopardized, thereby impacting the long-term oncological outcome.1
Laparoscopic surgery for colon cancer has become widely accepted and imple-
mented in routine practice for localized disease (pT1-3). Both favorable short-term
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and long-term beneﬁts have been demonstrated,2–5 includ-
ing less postoperative complications, shorter hospital stay,
lower risks of adhesion-related small bowel obstruction,
and incisional hernia compared to open surgery.6 In the
multicenter randomized COLOR trial,7 the noninferiority
of laparoscopic surgery for pT1-4 colon cancer in terms of
oncological outcomes (3-year disease-free survival, DFS)
was suggested. However, clinically suspected tumor inva-
sion of adjacent structures (cT4b stage) and emergency
surgery were exclusion criteria. Due to a conversion rate
of about 50% for the remaining T4 tumors in the COLOR
data, the authors presumed the open approach to be most
appropriate for T4 colon cancer.
Experience with laparoscopic surgery for T4 tumors
increases, and the concerns on achieving radicality of
resection may be outdated. Accumulating series of laparo-
scopic resections of T4 colon cancer are published,8–18 and
two recent meta-analyses19,20 show comparable rates of
R0 resections and long-term oncological outcomes after
laparoscopic versus open surgery. However, only a limited
body of evidence is available and is restricted to retro-
spective series with substantial allocation bias.19,20 Also,
emergency cases and multivisceral resections (MVR,
pT4b) were often excluded in the previous series.
The aim of this multicenter cohort study was to eval-
uate long-term oncological outcomes after curative intent
laparoscopic surgery for pT4 colon cancer and compare it
to open surgery using propensity score analyses in order to
correct for allocation bias.
Methods
Patients and databases
In this cohort study, four prospectively maintained data-
bases of the University Hospital Leuven, the Dutch (teach-
ing) St. Antonius Hospital, and two Dutch university
medical centers (Radboud UMC and Amsterdam UMC)
were combined (centers 1–4). The database of center 1
contained all consecutive patients who underwent resec-
tion of colon cancer between January 2004 and July 2013.
The databases of centers 2 and 3 included all pT4 color-
ectal cancer patients undergoing surgery between January
2000 and December 2013, and between January 2000 and
December 2007, respectively. The database of center 4
included all pT4 colon cancer patients who underwent
surgery between January 2004 and December 2014.
Patients undergoing a curative intent pT4N0-2M0 primary
colon cancer resection were included. Patients with a
macroscopic incomplete (R2) resection or with an inade-
quate pathological or surgical report were excluded.
Adjuvant chemotherapy was administered according to
the national protocols: indicated in high-risk stage II and
stage III, consisting of 5-ﬂourouracil or capecitabine and
preferably combined with oxaliplatin (FOLFOX or
CAPOX) since 2005, for a total duration of 6 months.
Follow-up was performed according to the national proto-
col and data were collected until April 2018.21,22 This
study was waived from the review of the medical ethics
boards, since the prospective data collection did not inter-
fere with the psychological integrity of the patients. The
study is reported in accordance with the STROBE
checklist.
Variables and outcomes
The pT4 stage was subdivided into pT4a and pT4b accord-
ing to TNM7:23 pT4a refers to tumors perforating the
visceral peritoneum and pT4b refers to tumors directly
invading other organs or structures. MVR could be either
limited or extensive: limited additional resection included
the abdominal wall, the omentum, or the ovaries, and
extensive resection was deﬁned as resections including
the pancreas, spleen, kidney, liver, stomach, bladder,
ureters, uterus, or additional bowel segments.
The primary outcome measures were DFS and overall
survival (OS). Secondary outcomes were radicality of
resection, classiﬁed as R0 (radical resection) and R1
(microscopically irradical resection) resections, adminis-
tration of adjuvant chemotherapy, and postoperative com-
plications (<30 days or in hospital). Postoperative
complications were registered if the Clavien–Dindo24
(CD) score was 2 or higher. Postoperative morbidity was
deﬁned as CD 2–4, and postoperative mortality as CD5.
Statistical analyses
The laparoscopic converted procedures were included in
the laparoscopic group according to “intention-to-treat
principle”. For each patient, a propensity score was calcu-
lated, displaying the probability of receiving laparoscopic
surgery based on a multivariable logistic regression model
including (potential) confounding baseline variables.
Potential confounders were variables only affecting out-
come measures, and true confounders were variables
affecting both choice for surgical approach and outcome
measures.25 Confounders included age, emergency setting,
tumor location (right/left), MVR (none/limited/extended),
N-stage, and histopathology. The choice for variables
Wasmann et al Dovepress
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included in the model was based on identiﬁed (potential)
confounders in the previous series.8,9,11,19 Due to multi-
collinearity between MVR and T4 subcategory (T4a/T4b),
the latter was not included in the propensity score
calculation.
The propensity score was used in three different man-
ners to adjust for group differences, all with distinct
advantages and disadvantages.25,26 Firstly, the propensity
score was used as a linear predictor in Cox regression
analyses (referred to as “Regression adjusted”), from
which an estimated effect was derived. In this way, the
entire cohort could be included in the analysis. In order to
minimize baseline differences before statistical compari-
son, the propensity score was used for 1:1 matching with a
caliper width of 0.02 and using matching without replace-
ment (referred to as “Matched cohort”). Besides compar-
ison of the two matched cohorts, the excluded cohort of
open surgery after matching was analyzed and compared
to the included matched open cohort. Thirdly, the propen-
sity score was used to subdivide patients into four strata
based on quartiles of the propensity scores, creating an
equal distribution of confounding variables within the four
strata (referred to as ‘Strata 1–4ʹ). For each stratum, base-
line and outcome variables were compared between
laparoscopic and open subgroups. This method uses the
entire cohort and creates clinically relevant subgroups
from a surgical perspective. In addition, sensitivity ana-
lyses were performed for MVR and emergency surgery.
Differences in baseline characteristics between sub-
groups were assessed using a chi-square test for categorical
variables or a Fisher’s exact test in case of low counts (<5).
For normally distributed continuous variables, mean and SD
were reported. The survival analyses were performed using
Kaplan–Meier and Cox regression analyses. A p-value of
<0.05 was considered statistically signiﬁcant in the multi-
variable analyses. For statistical analyses, PASW Statistics,
version 24 (SPSS inc., Chicago, IL) was used.
Results
Patients
A total of 424 patients that underwent macroscopic com-
plete (R0/R1) resection of primary pT4N0-2M0 colon can-
cer in one of the four participating centers were included
(Figure S1). Mean age was 69 years (SD 12) and 51% of
patients were male. Laparoscopic surgery was performed in
131 patients (31%), of which 33 procedures were converted
(25%). A MVR was performed in 171 patients (40%) and
emergency surgery in 60 patients (14%). Median follow-up
was 48 months (IQR 22–60). Baseline characteristics are
displayed in Table 1. The following baseline characteristics
were signiﬁcantly different for the laparoscopic and open
groups, respectively: emergency setting (5% vs 18%,
p<0.001), MVR (31% vs 45%, p=0.014), and T4 subcate-
gory (T4a: 81% vs 66%, p=0.002).
Numbers of performed resections between the centers
were 164 (39%) in center 1, 113 (27%) in center 2, 90
(21%) in center 3, and 57 (13%) in center 4 with signiﬁ-
cantly different laparoscopy rates (42%, 24%, 3%, and
56%, respectively; p<0.001) and conversion rates (38%,
11%, 67%, and 6%, respectively; p=0.001). No differences
in case mix were found between centers 2, 3, and 4, while
center 1 showed higher rates of elective surgery and lower
rates of MVRs and pT4b tumors (Table S1).
Unadjusted analysis of outcome measures
The R0 resection rate was higher in the laparoscopic group
as compared to the open group (99% vs 93%, p=0.010).
The postoperative morbidity rate was lower after laparo-
scopic surgery (27% vs 46%, p<0.001) and postoperative
mortality rates were comparable (2% vs 3%, p=0.357).
Adjuvant chemotherapy was more often administered
after laparoscopic surgery (60% vs 44%, p=0.004).
Laparoscopy was signiﬁcantly associated with better
5-year DFS (52% vs 38%, p=0.008) and 5-year OS (68%
vs 57%, p=0.023) (Tables 2 and S2, Figures 1 and 2).
Regression adjusted analysis
The distributions of propensity scores are displayed in
Figure 1. After adjusting for the propensity score in regres-
sion models, R0 resection rate (OR 0.16; 95% CI 0.02–
1.25) as well as postoperative mortality (OR 0.73; 95%CI
0.14–3.68) were comparable between the two approaches,
while postoperative morbidity was lower (OR 0.48; 95%
CI 0.30–0.77) and the rate of administration of adjuvant
chemotherapy higher (OR 1.94; 95% CI 1.25–3.03) after
laparoscopic surgery. Five-year DFS was signiﬁcantly bet-
ter in the laparoscopic group (HR 0.70; 95% CI 0.52–
0.94), without signiﬁcant beneﬁt for 5-year OS (HR 0.73;
95%CI 0.50–1.06) (Figure 2).
Propensity matched analysis
In Figure 1, the distributions of propensity scores are dis-
played for the propensity matched cohort. Within the pro-
pensity matched cohort (n=262), no baseline differences
were found between the laparoscopic and open groups
(Table 3), apart from the center. The excluded open group
Dovepress Wasmann et al
Cancer Management and Research 2019:11 submit your manuscript | www.dovepress.com
DovePress
7143
 
Ca
nc
er
 M
an
ag
em
en
t a
nd
 R
es
ea
rc
h 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
14
9 
on
 0
2-
Se
p-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
(n=162) after 1:1 matching contained more emergency
cases as compared to the included open group (29% vs
5%, p<0.001) as well as more MVRs (57% vs 29%,
p<0.001) and more pT4b tumors (44% vs 21%, p<0.001).
Laparoscopic surgery as compared to open surgery in
the 1:1 matched cohort revealed higher R0 resection
rates (99% vs 95%, p=0.030), lower postoperative mor-
bidity (27% vs 72%, p<0.001), a trend toward lower
postoperative mortality (2% vs 8%, p=0.051), and com-
parable rates of administration of adjuvant chemother-
apy (60% vs 54%, p=0.301). Five-year DFS was
signiﬁcantly better in the laparoscopic group (52% vs
Table 1 Baseline characteristics of the entire cohort for the laparoscopic and the open group
Lap (n=131) Open (n=293)
n % n % p-Value
Gender Male 68 52% 148 51% 0.790
Female 63 48% 145 49%
Age ≤60 29 22% 73 25% 0.783
61–70 37 28% 75 26%
71–80 41 31% 99 34%
≥81 24 18% 46 16%
Hospital Center 1 69 53% 95 32% <0.001
Center 2 27 21% 86 29%
Center 3 3 2% 87 30%
Center 4 32 24% 25 9%
Location tumour Right 56 43% 126 43% 0.961
Left/transverse 75 57% 167 57%
Surgical procedure (Extended) right hemicolectomy 60 46% 127 43% 0.140
Transverse resection 0 0% 8 3%
(Extended) left hemicolectomy 13 10% 42 14%
(Low) anterior/sigmoid resection 51 39% 94 32%
Subtotal/panprocto-colectomy 7 5% 22 8%
Setting Elective 125 95% 239 82% <0.001
Emergency 6 5% 54 18%
Neoadjuvant therapy Yes 5 4% 14 5% 0.681
No 124 96% 279 95%
MVR No 91 69% 162 55% 0.014
Yes, limited 19 15% 50 17%
Yes, extended 21 16% 81 28%
Conversion 33 25% NA NA
pT-stage T4a 106 81% 193 66% 0.002
T4b 25 19% 100 34%
pN-stage N0 64 49% 139 47% 0.963
N1 38 29% 88 30%
N2 29 22% 66 23%
Histology Adenocarcinoma (well diff) 94 72% 197 67% 0.333
Adenocarcinoma (poorly/undiff) 15 11% 50 17%
Mucinous/signet ring cells 22 17% 46 16%
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach; pT/N, pathological T/N-stage; Undiff, undifferentiated;
Well diff, well differentiated.
Wasmann et al Dovepress
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40%, p=0.038), as well as 5-year OS (68% vs 57%,
p=0.044) (Figure 1). Survival rates of patients that
were excluded from the open group after propensity
matching were comparable with the included open
group (5-year DFS 37%, p=0.664 and 5-year OS 57%,
p=0.914).
Propensity score–based strata
After dividing the entire cohort into four strata based on
quartiles of the propensity scores, with stratum 1 containing
the lowest propensity for laparoscopic surgery, the R0
resection rates were higher in all strata (although nonsigni-
ﬁcant), postoperative morbidity, mainly CD2 complications,
was lower in stratum 4 (22% vs 43%, p=0.031), adjuvant
chemotherapy higher in strata 2 and 3 and survival out-
comes favorable in all strata (although nonsigniﬁcant) after
laparoscopic surgery vs open (Table 2 and Figure 2).
Baseline characteristics of the four strata are provided in
Table S3–S6. Stratum 1 contains all emergency cases as
well as the highest percentage of extended MVRs (50%).
Stratum 2 also includes a high percentage of MVRs (limited
MVR 30%, extended MVR 47%), whereas the MVR rates
of strata 3 and 4 are 16% and 0%, respectively.
Sensitivity analyses
After sensitivity analyses, no subgroup of patients (eg emer-
gency setting) could be identiﬁed in which oncological
outcomes of laparoscopic surgery were inferior to outcomes
after open surgery (Table 2 and Figure 2). In the “no-MVR”
subgroup, DFS and OS were signiﬁcantly better, and in the
extended MVR and elective cases, more adjuvant che-
motherapy was administered after laparoscopic surgery as
compared to open surgery. For elective cases also, a sig-
niﬁcant better DFS was seen after laparoscopy.
Adjuvant chemotherapy
Post hoc analyses showed that after adjusting for adjuvant
chemotherapy in the Cox regression models, the beneﬁcial
effect of laparoscopic surgery on DFS and OS did not remain
signiﬁcant, neither in the unadjusted nor in the regression
adjusted and the 1:1 matched cohort. In every multivariable
model, adjuvant chemotherapy was signiﬁcantly associated
with improved DFS (HR 0.46; 95% CI 0.35–0.61, HR 0.54;
95% CI 0.41–0.71 and HR 0.37; 95% CI 0.24–0.56, respec-
tively) andOS (HR 0.49; 95%CI 0.33–0.72, HR 0.44; 95%CI
0.31–0.62 andHR 0.31; 95%CI 0.19–0.51, respectively), both
in stage II and stage III subgroups (data not shown).
Discussion
In this multicenter series of 424 pT4N0-2M0 colon cancer
patients who underwent curative intent surgery, laparoscopic
surgery was associated with reduced postoperative morbidity
and a higher percentage of patients receiving adjuvant che-
motherapy. The multivariable models revealed an independent
association of adjuvant chemotherapy with improved survival,
but not surgical approach. This suggests that laparoscopic
surgery facilitates the administration of adjuvant chemother-
apy by improving postoperative recovery and reducing com-
plication rates, with ultimate gain in survival.
Table 2 Short-term oncological outcomes after laparoscopic and open surgery
Lap/Open Radicality Adj. chemo
Lap Open p-Value Lap Open p-Value
Unadjusted 131/293 130 (99%) 271 (93%) 0.010* 75 (60%) 127 (44%) 0.004
Propensity score adjusted models
Matched cohort 131/131 130 (99%) 123 (95%) 0.030* 75 (60%) 68 (54%) 0.301
Stratum 1 15/90 15 (100%) 78 (89%) 0.191 9 (53%) 41 (47%) 0.233
Stratum 2 32/75 31 (97%) 68 (92%) 0.317 20 (69%) 28 (37%) 0.004
Stratum 3 39/69 39 (100%) 66 (96%) 0.257 26 (70%) 33 (45%) 0.027
Stratum 4 45/59 45 (100%) 59 (100%) 20 (44%) 25 (46%) 0.920
Sensitivity analyses
No MVR 91/162 90 (99%) 157 (97%) 0.298 53 (60%) 74 (48%) 0.061
Limited MVR 19/50 19 (100%) 45 (90%) 0.152 7 (44%) 17 (34%) 0.338
Extended MVR 21/81 21 (100%) 69 (89%) 0.103 15 (71%) 36 (44%) 0.028
Elective 125/239 124 (99%) 223 (95%) 0.027* 72 (60%) 107 (46%) 0.010
Emergency 6/54 6 (100%) 48 (89%) 0.516 3 (60%) 20 (39%) 0.330
Abbreviations:Adj. chemo, adjuvant chemotherapy; Lap, laparoscopic approach; MVR, multivisceral resection; Open, open approach; Unadjusted, the unadjusted (entire) cohort.
Dovepress Wasmann et al
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A recently published Chinese expert series27 similarly
observed higher survival rates after laparoscopic surgery
(5-year DFS 57% vs 40%, p=0.053, 5-year OS 61% vs
47%, p=0.060). The increased likelihood of receiving
adjuvant chemotherapy due to better recovery from mini-
mally invasive surgery has also recently been observed.
30
Entire cohort (n=424) Propensity matched cohort (n=262)
DFS
OS OS
DFS
Open (excluded)
Open (included)
LaparoscopicOpenLaparoscopic
Open
Laparoscopic
Laparoscopic
0
131
293
0
131
131
162
12
114
108
137
24
102
94
119
36
91
79
101
48
70
57
88
60
53
44
74
12
114
245
24
102
213
36
91
180
48
70
145
60
53
118Open
Open (excluded)
Open (included)
Laparoscopic
20
10
0
30
20
10
0
1,0
P=0.008*
P=0.023*
P=0.038*
P=0.664
P=0.044*
P=0914
0,8
0,6
0,4
0,2
0,0
0 10 20 30 40 50 60 0 10 20 30 40 50 60
0 10 20 30 40 50 600 10 20
Time (months)
Time (months)
Laparoscopic
0
131
293
12
103
207
24
89
148
36
71
125
48
53
102
60
37
84Open
Time (months)
Laparoscopic
Open (incl)
Open (excl)
Time (months)
0
131
131
162
12
103
93
114
24
89
66
82
36
71
58
67
48
53
44
58
60
37
33
51
Laparoscopic
Open (incl)
Open (excl)
Time (months)
Time (months)
30 40 50 60
1,0
0,8
0,6
0,4
0,2
0,0
1,0
0,8
0,6
0,4
0,2
0,0
1,0
0,8
0,6
0,4
0,2
0,0
30
20
10
0
30
20
10
0
.10.00 .20
Propensity score
Time (months) Time (months)
Fr
eq
ue
nc
y Approach
O
pen
Laparoscopic
A
pproach
O
pen
Laparoscopic
Fr
eq
ue
nc
y
C
um
 s
ur
vi
va
l
C
um
 s
ur
vi
va
l
C
um
 s
ur
vi
va
l
C
um
 s
ur
vi
va
l
Propensity score
.30 .40 .50 .10.00 .20 .30 .40 .50
Figure 1 Propensity score distribution, disease-free survival (DFS), and overall survival (OS) in the entire cohort and the propensity matched cohort.
Abbreviations: Laparoscopic, laparoscopic approach; Open, open approach; DFS, disease-free survival; OS, overall survival; cum, cumulative; open (excl), open approach,
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Lee et al reported higher rates and less delay to the initia-
tion of adjuvant chemotherapy after laparoscopic surgery
for stage III colon cancer in a propensity matched cohort
of 66,266 patients, ultimately resulting in improved survi-
val. But this is a new insight that has not previously been
described in the literature.28 In randomized controlled
trials, such as the COLOR trial,7 comparable rates of
adjuvant chemotherapy and survival after laparoscopic
and open surgery are likely related to strict inclusion of
relatively ﬁt patients with small tumors, being operated
upon in the elective setting. Therefore, randomized con-
trolled trials have restricted external validity. We hypothe-
size that more extended application of laparoscopy by
experienced surgeons in routine practice is now going to
shed a different light on the impact of minimally invasive
surgery. The most pronounced differences in administra-
tion of adjuvant chemotherapy between laparoscopy and
open surgery were found in the extended MVR subgroup
(71% vs 44%) and in the emergency setting (60% vs 39%),
suggesting that minimizing surgical trauma is only becom-
ing clinically relevant in such high-risk patients. Two
series including substantial numbers of T4b cases also
reported higher rates of adjuvant chemotherapy after
laparoscopic as compared to open surgery (63% vs 37%,
p=0.047 and 71% vs 57%, p=0.513).13,16
The main reason why T4 colon cancer has been con-
sidered a contraindication for laparoscopic surgery was the
concern about achieving complete resection with negative
margins, especially in the case of local ingrowth (pT4b). In
this multicenter series, a 100% R0 resection rate in 40
patients requiring MVR was found. Four studies assessed
outcomes after laparoscopic resection of pT4b colon cancer
in relatively small cohorts of 15–23 patients.9,11,13,20,29 R0
resection rates were 83%, 93%, 96%, and 100%, respec-
tively. For experienced surgeons in open MVR who also
completed the learning curve for laparoscopic colon sur-
gery, the laparoscopic approach might eventually facilitate
dissection in locally advanced cases. This is related to the
magniﬁed view at high resolution with a 30-degree camera
that enables optimal visualization from different angles,
which, for example, might improve dissection from the
retroperitoneum below a bulky tumor as compared to med-
ian laparotomy. It is often considered that tactile feedback is
missing in laparoscopy, but there is still an indirect sense of
ﬁrmness of tissues. Furthermore, high-quality MVR has
become more and more dependent on thorough preoperative
Cohort
Unadjusted 131/293
131/131
DFS
HR (95% CI)
0.673 (0.501-0.904) P=0.009* 
0.658 (0.458-0.949) P=0.025* 
0.697 (0.515-0.944) P=0.020* 
0.732 (0.503-1.064) P=0.102
0.700 (0.497-0.985) P=0.041
0.655 (0.432-0.994) P=0.045*
0.456 (0.182-1.139) P=0.093
0.683 (0.386-1.211) P=0.192
0.733 (0.368-1.460) P=0.377
0.668 (0.381-1.172) P=0.159
0.973 (0.500-1.893) P=0.393
0.887 (0.508-1.550) P=0.675
0.606 (0.274-1.340) P=0.216
0.646 (0.447-0.934) P=0.20*
0.556 (0.343-0.900) P=0.17*
0.957 (0.493-1.859) P=0.897
1.049 (0.487-2.259) P=0.902
0.495 (0.223-1.098) P=0.084
0.787 (0.346-1.787) P=0.567
0.730 (0.537-0.992) P=0.044*
0.735 (0.503-1.076) P=0.113
0.216 (0.030-1.578) P=0.131
0.293 (0.040-2.151) P=0.227
0.626 (0.249-1.578) P=0.321
OS
n lap/open
Propensity score adjusted models
Sensitivity analyses
No MVR
Limited MVR
Extended MVR
Elective
Emergency
Regression adjusted 131/293
Matched cohort
Stratum 1
Stratum 2
Stratum 3
Stratum 4 45/59
91/162
19/50
21/81
125/239
6/54
0.0 0.5 1.0 1.5 2.0
39/69
32/75
15/90
Favours laparoscopy Favours open
Figure 2 Disease-free (DFS) and overall survival (OS).
Abbreviations: Lap, laparoscopic approach; MVR, multiviscersal resection; Open, open approach; unadjusted, the unadjusted (entire) cohort; DFS, disease-free survival;
OS, overall survival; HR, hazard ratio; CI, conﬁdence interval.
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anatomical planning of the surgical planes of dissection.
Performing minimally invasive surgery increases the skills
in intraoperative recognition of (disturbed) anatomy. The
proven better hemostatic dissection with less blood loss also
favors the laparoscopic approach. Even if a larger incision
is needed for extraction of a bulky pT4b tumor, laparoscopy
might be the preferred approach by reducing surgical stress
response and because of ﬂexibility in the site of extraction
to reduce the risk of incisional hernia (eg Pfannenstiel).
Occurrence of severe postoperative complications is an
important factor that precludes the use of adjuvant
chemotherapy.30 Postoperative infection requiring re-inter-
vention (CD3) or ICU admission (CD4) were highest in the
extended MVR and emergency subgroups undergoing open
Table 3 Baseline characteristics of the matched cohort for the laparoscopic and the open group
Lap (n=131) Open (n=131) p-Value Open excl (n=162)
n % n % n %
Gender Male 68 52% 68 52% 1.000 80 49%
Female 63 48% 63 48% 82 51%
Age ≤60 29 22% 31 24% 0.924 42 26%
61–70 37 28% 37 28% 38 24%
71–80 41 31% 43 33% 56 35%
≥81 24 18% 20 15% 26 16%
Hospital Center 1 69 53% 47 36% <0.001 48 30%
Center 2 27 21% 28 21% 58 36%
Center 3 3 2% 45 34% 42 26%
Center 4 32 24% 11 8% 14 9%
Location tumour Right 56 43% 51 39% 0.530 75 46%
Left/transverse 75 57% 80 61% 87 54%
Surgical procedure (Extended) right hemicolectomy 60 46% 51 39% 0.071 76 47%
Transverse resection 0 0% 5 4% 3 2%
(Extended) left
Hemicolectomy 13 10% 20 15% 22 13%
(Low) anterior/sigmoid resection 51 39% 44 34% 50 31%
Subtotal/panprocto-colectomy 7 5% 11 8% 11 7%
Setting Elective 125 95% 124 95% 0.776 115 71%
Emergency 6 5% 7 5% 47 29%
Neoadjuvant therapy Yes 5 4% 8 7% 0.409 6 4%
No 124 96% 123 93% 156 96%
MVR No 91 70% 93 71% 0.747 69 43%
Yes, limited 19 15% 15 12% 35 22%
Yes, extended 21 16% 23 17% 58 36%
Conversion 33 25% NA NA NA
pT-stage T4a 106 81% 103 79% 0.645 90 56%
T4b 25 19% 28 21% 72 44%
pN-stage N0 64 49% 63 48% 0.830 76 47%
N1 38 29% 42 32% 46 28%
N2 29 22% 26 20% 40 25%
Histology Adenocarcinoma (well diff) 94 72% 96 73% 0.872 101 62%
Adenocarcinoma (poorly/undiff) 15 11% 16 12% 34 21%
Mucinous/signet ring cells 22 17% 19 15% 27 17%
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach; Open excl, open approach, excluded from the
matched cohort; pT/N, pathological T/N-stage; Undiff, undifferentiated; Well diff, well differentiated.
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surgery (31% and 28%, respectively). This likely reduced
the possibilities of administration of adjuvant chemotherapy
in these subgroups. Moreover, it has been increasingly
described in the literature that postoperative complications
have an independent adverse effect on oncological out-
comes, possibly related to upregulation of inﬂammatory
cytokines that enhance tumor progression.31–33
Previously published series comparing laparoscopic and
open surgery for pT4 colon cancer often address the issue of
allocation bias with more advanced cases in the open sub-
group contained. In this analysis, we have attempted to
overcome this bias by using propensity scores and by not
excluding MVR and emergency cases. Propensity scores
control for baseline differences inherent to observational
studies.25 However, the present analysis might still be sub-
ject to allocation bias. We have only roughly subdivided
MVRs in “limited” and “extended”, while still the more
complex extended MVRs could be assigned to the open
subgroup. Furthermore, the number of emergency cases
were limited. We did not correct for effects such as tumor
size, presence of intraabdominal infections, presence
of adhesions, body mass index, and comorbidity.
Consequently, hidden confounding by allocation to laparo-
scopic or open surgery (selecting patients) could have
occurred for which propensity score analyses do not correct.
Nonetheless, we have implemented the propensity scores
using different manners and results were comparable
amongst all analyses. This represents the best achievable
evidence, as new RCTs comparing surgical approach in T4
colon cancer are unlikely to be conducted. Previous RCTs
comparing surgical techniques have struggled with differ-
ences in completion of learning curves amongst the partici-
pating surgeons.34–36 Rouanet et al proposed to compare a
series of expert centers that apply different surgical techni-
ques as an alternative for RCTs, in this way overcoming the
problems of learning curves and allocation bias.37 Our study
approaches this methodology to some extent, by including
two centers (1 and 4) with relatively high laparoscopic
surgery rates (42% and 56%), and one participating hospital
applying open surgery in 97% of cases, with comparable
case mixes. However, the conversion rate of 38% in center
1 suggests that the learning curve has not been fully com-
pleted during the study period.
Another limitation of the study is the retrospective
data collection with difﬁculties in the uniformity of
deﬁning variables and potential underestimation of the
postoperative complication rate. However, postoperative
complication rates among the four hospitals were com-
parable or even higher than previously published.38
Conclusion
In conclusion, this multicenter cohort study showed that
laparoscopic surgery for pT4 colon cancer was associated
with a lower risk of postoperative morbidity and a higher
chance of receiving adjuvant chemotherapy. Receiving adju-
vant chemotherapy was independently associated with better
survival, which indicates an indirect impact of surgical
approach on oncological outcome. However, these results
might not be generalizable due to the level of experience in
advanced laparoscopic surgery. Centralization of care for
pT4 colon cancer should be aimed for, and future series of
expert centers performing laparoscopic surgery for T4 colon
cancer, especially in the more technically challenging cases,
should further conﬁrm our hypothesis.
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Supplementary materials
pT4NxMx colorectal cancer, n=997
UZ Leuven
Jan 2004-Jul 2013
Inclusion: colorectal cancer
N=483
St. Antonius Hospital
Jan 2000-Dec 2007
Inclusion: pT4NxMx colorectal cancer
N=200
Radboud UMC
Jan 2003-Dec 2013
Inclusion: pT4NxMx colorectal cancer
N=201
AMC
Jan 2004-Dec 2015
Inclusion: pT4NxMx colon cancer
N=93
Rectum, n=149
Non-curative intent/R2 resection,
n=135
M1 disease, n=265
Liver metastases: n=146
Lung metastases: n=30
Peritoneal metastases: n=135
Surgery and/or pathology report
missing
n=52
pT4NxMx colon cancer, n=848
pT4NxMx colon cancer, n=713
Curative intent resection for pT4NxM0
colon cancer, n=473
Included in analysis, n=424
Figure S1 Patients included in the analysis.
Abbreviations: pT/N, pathological T/N-stage; R2, macroscopically irradical resection; M1, metastatic disease; UZ, University hospital Leuven; Radboud UMC, Radboud
University Medical Centre; AMC, Amsterdam University Medical Centre, location academic medical centre; Jan, January; Jul, July; Dec, December.
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Table S2 Short-term outcomes after laparoscopic and open surgery; postoperative morbidity
Lap/
Open
Postop Complications
(CD2)
Postop Complications
(CD3/4)
Postop Mortality (CD5)
Lap Open p-value Lap Open p-value Lap Open p-value
Unadjusted 131/293 19 (15%) 66 (23%) 0.057 14(11%) 61(21%) 0.012 2 (2%) 8 (3%) 0.357
Propensity score adjusted
models
Matched cohort 131/131 19 (15%) 41 (31%) 0.001 14 (11%) 45 (34%) 0.001 2 (2%) 8 (6%) 0.051
Stratum 1 15/90 5 (33%) 20 (22%) 0.350 1 (7%) 23 (26%) 0.182 0 (0%) 5 (5.6%) 0.455
Stratum 2 32/75 6 (19%) 15 (20%) 0.882 2 (6%) 19 (25%) 0.032 1 (3%) 1 (1%) 0.511
Stratum 3 39/69 5 (13%) 14 (20%) 0.327 5 (13%) 12 (17%) 0.531 0 (0%) 1 (1%) 0.639
Stratum 4 45/59 3 (7%) 17 (29%) 0.005 6 (13%) 7 (12%) 0.822 1 (2%) 1 (2%) 0.681
Sensitivity analyses
No MVR 91/162 9 (10%) 37 (23%) 0.010 11 (12%) 28 (17%) 0.272 1 (1%) 3 (2%) 0.546
Limited MVR 19/50 4 (21%) 10 (20%) 1.000 1 (5%) 8 (16%) 0.237 1 (5%) 2 (4%) 0.626
Extended MVR 21/81 6 (29%) 19 (24%) 0.627 2 (10%) 25 (31%) 0.048 0 (0%) 3 (4%) 0.371
Elective 125/239 17 (14%) 55 (23%) 0.032 13 (10%) 46 (19%) 0.030 2 (2%) 5 (2%) 0.745
Emergency 6/54 2 (33%) 11 (20%) 0.602 1 (17%) 15 (28%) 0.559 0 (0%) 3 (6%) 0.725
Abbreviations: CD, Clavien-Dindo score; Lap, laparoscopic approach; MVR, multivisceral resection; Open, open approach; Unadjusted, the unadjusted (entire) cohort.
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Table S3 Baseline characteristics of stratum 1 (lowest propensity for laparoscopic surgery) for the laparoscopic and the open group
Laparoscopic (n=15) Open (n=90) p-value
n % n %
Gender Male 7 47% 53 59% 0.376
Female 8 53% 37 41%
Age ≤60 3 20% 27 30% 0.621
61-70 3 20% 15 17%
71-80 8 53% 35 39%
≥81 1 7% 13 14%
Hospital Center 1 5 33% 24 27% 0.001
Center 2 2 13% 26 29%
Center 3 1 7% 31 34%
Center 4 7 47% 9 10%
Location tumour Right 10 67% 36 40% 0.054
Left/transverse 5 33% 54 60%
Surgical procedure (Extended) right hemicolectomy 8 53% 36 40% 0.811
Transverse resection 0 0% 3 3%
(Extended) left hemicolectomy 1 7% 12 13%
(Low) anterior/sigmoid resection 5 33% 31 34%
Subtotal/panprocto-colectomy 1 7% 8 9%
Setting Elective 9 60% 36 40% 0.147
Emergency 6 40% 54 60%
Neoadjuvant therapy Yes 0 0% 2 2% 0.762
No 13 100% 88 98%
MVR No 4 27% 29 32% 0.911
Yes, limited 3 20% 17 19%
Yes, extended 8 53% 44 49%
Conversion 4 27%
T-stage T4a 8 53% 45 50% 0.811
T4b 7 47% 45 50%
N-stage N0 9 60% 40 44% 0.515
N1 4 27% 30 33%
N2 2 13% 20 22%
Histology Adenocarcinoma (well diff) 8 53% 49 54% 0.570
Adenocarcinoma (poorly/undiff) 6 40% 27 30%
Mucinous/signet ring cells 1 7% 14 16%
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach; pT/N, pathological T/N-stage; Undiff, undifferentiated;
Well diff, well differentiated.
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Table S4 Baseline characteristics of stratum 2 for the laparoscopic and the open group
Laparoscopic (n=32) Open (n=75) p-value
n % n %
Gender Male 16 50% 33 44% 0.568
Female 16 50% 42 56%
Age ≤60 8 25% 20 27% 0.416
61-70 14 44% 21 28%
71-80 7 22% 25 33%
≥81 3 9% 9 12%
Hospital Center 1 19 59% 20 27% 0.001
Center 2 5 16% 25 33%
Center 3 2 6% 22 29%
Center 4 6 19% 8 11%
Location tumour Right 15 47% 30 40% 0.510
Left/transverse 17 53% 45 60%
Surgical procedure (Extended) right hemicolectomy 14 44% 32 43% 0.673
Transverse resection 0 0% 2 3%
(Extended) left hemicolectomy 4 13% 6 8%
(Low) anterior/sigmoid resection 12 37% 33 44%
Subtotal/panprocto-colectomy 2 6% 2 3%
Setting Elective 32 100% 75 100%
Emergency 0 0% 0 0%
Neoadjuvant therapy Yes 30 94% 65 87% 0.240
No 2 6% 10 13%
MVR No 7 22% 18 24% 0.525
Yes, limited 12 38% 20 27%
Yes, extended 13 41% 37 49%
Conversion 16 50%
T-stage T4a 17 53% 30 40% 0.210
T4b 15 47% 45 60%
N-stage N0 15 47% 39 52% 0.874
N1 9 28% 20 27%
N2 8 25% 16 21%
Histology Adenocarcinoma (well diff) 21 66% 47 63% 0.955
Adenocarcinoma (poorly/undiff) 8 25% 20 27%
Mucinous/signet ring cells 3 9% 8 11%
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach, pT/N: pathological T/N-stage, Undiff: undifferentiated;
Well diff, well differentiated.
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Table S5 Baseline characteristics of stratum 3 for the laparoscopic and the open group
Laparoscopic (n=39) Open (n=69) p-value
n % n %
Gender Male 21 54% 38 55% 0.902
Female 18 46% 31 45%
Age ≤60 15 38% 21 30% 0.151
61-70 2 5% 12 17%
71-80 15 39% 30 44%
≥81 7 18% 6 9%
Hospital Center 1 23 59% 23 33% <0.001
Center 2 8 21% 21 30%
Center 3 0 0% 19 28%
Center 4 8 21% 6 9%
Location tumour Right 22 56% 41 59% 0.761
Left/transverse 17 44% 28 41%
Surgical procedure (Extended) right hemicolectomy 22 56% 39 57% 0.167
Transverse resection 0 0% 2 3%
(Extended) left hemicolectomy 2 5% 11 16%
(Low) anterior/sigmoid resection 13 33% 12 17%
Subtotal/panprocto-colectomy 2 5% 5 7%
Setting Elective 39 100% 69 100%
Emergency 0 0% 0 0%
Neoadjuvant therapy Yes 3 8% 0 0% 0.045
No 36 92% 69 100%
MVR No 35 90% 56 81% 0.239
Yes, limited 4 10% 16 19%
Yes, extended 0 0% 0 0%
Conversion 8 21%
T-stage T4a 36 92% 59 86% 0.369
T4b 3 8% 10 14%
N-stage N0 9 23% 19 28% 0.877
N1 16 41% 27 39%
N2 14 36% 23 33%
Histology Adenocarcinoma (well diff) 28 71% 47 69% 0.862
Adenocarcinoma (poorly/undiff) 1 3% 3 4%
Mucinous/signet ring cells 10 26% 19 28%
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach; pT/N, pathological T/N-stage; Undiff, undifferentiated;
Well diff, well differentiated.
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Table S6 Baseline characteristics of stratum 4 (highest propensity for laparoscopic surgery) for the laparoscopic and the open group
Laparoscopic (n=45) Open (n=59) p-value
n % n %
Gender Male 24 53% 24 41% 0.200
Female 21 47% 35 59%
Age ≤60 3 7% 5 9% 0.694
61–70 18 40% 27 46%
71–80 11 24% 9 15%
≥81 13 29% 18 31%
Hospital Center 1 22 49% 28 48% <0.001
Center 2 12 27% 14 24%
Center 3 0 0% 15 25%
Center 4 11 24% 2 3%
Location tumour Right 9 20% 19 32% 0.165
Left/transverse 36 80% 40 68%
Surgical procedure (Extended) right hemicolectomy 16 36% 20 34% 0.263
Transverse resection 0 0% 1 2%
(Extended) left hemicolectomy 6 13% 13 22%
(Low) anterior/sigmoid resection 21 47% 18 31%
Subtotal/panprocto-colectomy 2 4% 7 12%
Setting Elective 45 100% 59 100%
Emergency 0 0% 0 0%
Neoadjuvant therapy Yes 0 0% 2 3% 0.212
No 45 100% 57 97%
MVR No 45 100% 59 100%
Yes, limited 0 0% 0 0%
Yes, extended 0 0% 0 0%
Conversion 5 14%
T-stage T4a 45 100% 59 100%
T4b 0 0% 0 0%
N-stage N0 31 69% 41 70% 0.981
N1 9 20% 11 19%
N2 5 11% 7 12%
Histology Adenocarcinoma (well diff) 37 82% 54 91% 0.155
Adenocarcinoma (poorly/undiff) 0 0 0 0%
Mucinous/signet ring cells 8 18% 5 9
Abbreviations: Lap, laparoscopic approach; MVR, multivisceral resection; NA, not applicable; Open, open approach; pT/N, pathological T/N-stage; Undiff, undifferentiated;
Well diff: well differentiated.
Dovepress Wasmann et al
Cancer Management and Research 2019:11 submit your manuscript | www.dovepress.com
DovePress
7157
 
Ca
nc
er
 M
an
ag
em
en
t a
nd
 R
es
ea
rc
h 
do
wn
lo
ad
ed
 fr
om
 h
ttp
s:
//w
ww
.d
ov
ep
re
ss
.c
om
/ b
y 
13
1.
17
4.
24
8.
14
9 
on
 0
2-
Se
p-
20
19
Fo
r p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
